抗尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记)
FITC-Linked Anti-Plasminogen Activator, Urokinase Receptor (uPAR) Polyclonal Antibody
CD87; PLAUR; PLAU-R; U-PAR; URKR; Monocyte Activation Antigen Mo3
用法
For flow cytometry, the suggested use of this reagent is 0.5-2 µl per 10^6 cells in 100 µl volume.
Optimal working dilutions must be determined by end user.
储存
Store at 4°C, protected from prolonged exposure to light.
赠品
增值服务
相关产品
| 编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
| RPA141Hu01 | 尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA141Hu02 | 尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA141Hu04 | 尿激酶型纤溶酶原激活因子受体(uPAR)活性蛋白 | Cell culture; Activity Assays. |
| RPA141Hu04 | 尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA141Hu03 | 尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA141Hu04 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体 | WB |
| PAA141Hu01 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体 | WB; IHC |
| PAA141Hu02 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体 | WB |
| PAA141Hu03 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体 | WB; IHC; ICC; IP. |
| LAA141Hu71 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| LAA141Hu83 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| LAA141Hu81 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| FAA141Hu81 | 抗尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记) | FCM |
| MAA141Hu22 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA141Hu21 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体 | WB |
| LAA141Hu82 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| SEA141Hu | 尿激酶型纤溶酶原激活因子受体(uPAR)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA141Hu | 尿激酶型纤溶酶原激活因子受体(uPAR)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| International Journal of Cancer | Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice[Wiley: source] |
| Biomark Insights | Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism[PubMed: PMC3623607] |
| Biomarker insights | Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD)[PubMed: PMC3762604] |
| Am J Emerg Med | Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis[PubMed: 26615223] |
| Archives of Clinical Infectious Diseases | Evaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis[Archcid: 26346] |
| The American Journal of Emergency Medicine | Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic Cavia (Guinea pig )idance of sepsis[science:S0735675715009559] |
| Journal of Clinical and Experimental Hepatology | Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) …[10.1016:j.jceh.2018.02.001] |
| Turkish journal of trauma & emergency surgery | The diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis[Pubmed: 31475329] |
| CELL TRANSPLANTATION | Predictive Value of Degranulating Factors of Neutrophils in Massive Cerebral Infarction[33787356] |


